Corebridge Financial’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,901	Closed	-$41.6K	–	193
2025 Q1	$41.6K	Sell	1,901 -24	-1%	-$525	﹤0.01%	2777
2024 Q4	$61.4K	Sell	1,925 -80	-4%	-$2.55K	﹤0.01%	2768
2024 Q3	$57.8K	Sell	2,005 -72	-3%	-$2.08K	﹤0.01%	2835
2024 Q2	$79.7K	Buy	+2,077	New	+$79.7K	﹤0.01%	2717